Lau G - Search Results

1

Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation.

Liu H, He X, Wang Y, Zhou S, Zhang D, Zhu J, He Q, Zhu Z, Li G, Sun L, Wang J, Cheng G, Liu Z, Lau G. Liu H, et al. Among authors: lau g. Hepatol Int. 2020 Jul;14(4):432-436. doi: 10.1007/s12072-020-10043-z. Epub 2020 Apr 10. Hepatol Int. 2020. PMID: 32277387 Free PMC article.

2

Chronic hepatitis B: a global health problem requiring coherent worldwide treatment strategies.

Lau G, Marcellin P, Peters M. Lau G, et al. Hepatol Int. 2007 Jun;1(2):316-25. doi: 10.1007/s12072-007-9006-5. Epub 2007 Jun 6. Hepatol Int. 2007. PMID: 19669356 Free PMC article.

3

Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients With Hepatitis C Treated With Direct-acting Antiviral Agents.

Wang C, Ji D, Chen J, Shao Q, Li B, Liu J, Wu V, Wong A, Wang Y, Zhang X, Lu L, Wong C, Tsang S, Zhang Z, Sun J, Hou J, Chen G, Lau G. Wang C, et al. Among authors: lau g. Clin Gastroenterol Hepatol. 2017 Jan;15(1):132-136. doi: 10.1016/j.cgh.2016.06.023. Epub 2016 Jul 5. Clin Gastroenterol Hepatol. 2017. PMID: 27392759

4

Twelve-week ribavirin-free direct-acting antivirals for treatment-experienced Chinese with HCV genotype 1b infection including cirrhotic patients.

Ji D, Chen GF, Wang C, Wang YD, Shao Q, Li B, Zhao J, You SL, Hu JH, Liu JL, Niu XX, Chen J, Lu L, Wu V, Lau G. Ji D, et al. Among authors: lau g. Hepatol Int. 2016 Sep;10(5):789-98. doi: 10.1007/s12072-016-9755-0. Epub 2016 Jul 21. Hepatol Int. 2016. PMID: 27443347

5

Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: A systematic review and meta-analysis.

Chen G, Wang C, Chen J, Ji D, Wang Y, Wu V, Karlberg J, Lau G. Chen G, et al. Among authors: lau g. Hepatology. 2017 Jul;66(1):13-26. doi: 10.1002/hep.29109. Epub 2017 May 27. Hepatology. 2017. PMID: 28195337 Review.

6

Diverse Changes of Circulating Fibroblast Growth Factor 21 Levels in Hepatitis B Virus-Related Diseases.

Wu L, Pan Q, Wu G, Qian L, Zhang J, Zhang L, Fang Q, Zang G, Wang Y, Lau G, Li H, Jia W. Wu L, et al. Among authors: lau g. Sci Rep. 2017 Nov 28;7(1):16482. doi: 10.1038/s41598-017-16312-6. Sci Rep. 2017. PMID: 29184085 Free PMC article.

7

Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL Score.

Ji D, Zhang D, Xu J, Chen Z, Yang T, Zhao P, Chen G, Cheng G, Wang Y, Bi J, Tan L, Lau G, Qin E. Ji D, et al. Among authors: lau g. Clin Infect Dis. 2020 Sep 12;71(6):1393-1399. doi: 10.1093/cid/ciaa414. Clin Infect Dis. 2020. PMID: 32271369 Free PMC article.

8

Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study.

Ji D, Qin E, Xu J, Zhang D, Cheng G, Wang Y, Lau G. Ji D, et al. Among authors: lau g. J Hepatol. 2020 Aug;73(2):451-453. doi: 10.1016/j.jhep.2020.03.044. Epub 2020 Apr 8. J Hepatol. 2020. PMID: 32278005 Free PMC article. No abstract available.

9

Reply to: 'No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease'.

Ji D, Xu J, Qin E, Zhang D, Cheng G, Wang Y, Lau G. Ji D, et al. Among authors: lau g. J Hepatol. 2020 Sep;73(3):718-719. doi: 10.1016/j.jhep.2020.04.039. Epub 2020 May 6. J Hepatol. 2020. PMID: 32387073 Free PMC article. No abstract available.

10

Reply to: 'NAFLD or comorbidities, that is the question'.

Ji D, Zhang D, Lau G. Ji D, et al. Among authors: lau g. J Hepatol. 2020 Sep;73(3):724-725. doi: 10.1016/j.jhep.2020.05.006. Epub 2020 May 12. J Hepatol. 2020. PMID: 32407814 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

784 results

Search Page